Search - tctmd.com

Displaying 81 - 100 of 185

Sort: Relevancy | Date

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

Presentation TCT Abstracts Posters 2018

Comparison of midterm outcome between small and non-small vessel after paclitaxel coated balloon treatment in de novo native coronary artery disease

Presenter: Ritsu Yoshida

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Presenter: Motoyoshi Maenaka

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Presenter: Motoyoshi Maenaka

September 25, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2017

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Saami K Yazdani

November 01, 2017

Presentation TCT 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice

November 01, 2017

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

TCT 57: Comparison of Particulate Embolization After Femoral Artery Treatment with IN.PACT Admiral, Ranger, and Stellarex Paclitaxel-Coated Balloons in Healthy Swine

Presenter: Sahil A. Parikh, Sho Torii, MD

October 31, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

Presentation TCT 2016

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries

Presenter: Martin B. Leon, Louis A. Cannon, Sean P. Lyden

November 02, 2016

Presentation TCT 2016

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Costantino Del Giudice

November 01, 2016

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr.

October 31, 2016

Presentation TCT 2016

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Presenter: Thomas F. Luscher, Patrick W. Serruys, D. Christopher Metzger

October 31, 2016

Presentation TCT 2016

TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment of Vascular Healing Response to Sirolimus and Paclitaxel-Eluting Stents

Presenter: Hector M. Garcia-Garcia, Ik-Kyung Jang, Mariusz Tomaniak

October 31, 2016

Presentation CCVVC 2016

Pathology of Drug Eluting Technologies: Are There Differences?

Presenter: Renu Virmani

June 15, 2016

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Cindy L. Grines, Upendra Kaul

October 14, 2015

Advertisement

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

Comparison of midterm outcome between small and non-small vessel after paclitaxel coated balloon treatment in de novo native coronary artery disease

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

TCT 57: Comparison of Particulate Embolization After Femoral Artery Treatment with IN.PACT Admiral, Ranger, and Stellarex Paclitaxel-Coated Balloons in Healthy Swine

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment of Vascular Healing Response to Sirolimus and Paclitaxel-Eluting Stents

Pathology of Drug Eluting Technologies: Are There Differences?

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content